[Treatment of vancomycin-resistant Enterococcus with linezolid in paediatric hospitals]. / Tratamiento de infecciones por Enterococcus resistente a vancomicina con linezolid en un hospital pediátrico.
Farm Hosp
; 31(1): 43-7, 2007.
Article
en Es
| MEDLINE
| ID: mdl-17439313
ABSTRACT
OBJECTIVE:
To describe the use of linezolid in vancomycin-resistant Enterococcus infections in a paediatric hospital.METHOD:
Retrospective, observational study of hospitalised patients at the "Juan P. Garrahan" paediatric hospital receiving linezolid for the treatment of vancomycin-resistant Enterococcus, during the period between January 2002 and July 2004.RESULTS:
During 18 months, linezolid was prescribed 17 times for a total of 15 seriously ill patients. The median age was 7 years old (range 1 month-15 years) and the median length of the treatment was 15 days, with an average hospital stay of 74 days. Infection with vancomycin-resistant Enterococcus was microbiologically documented in 11 (73.3%) patients; they all responded to treatment with linezolid with the exception of two, who died while receiving treatment. The most frequently reported adverse reactions were of a haematological nature (55.5%).CONCLUSIONS:
Linezolid was effective and moderately well tolerated for the treatment of vancomycin-resistant Enterococcus in children with life-threatening infections.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Vancomicina
/
Enterococcus faecium
/
Resistencia a la Vancomicina
/
Oxazolidinonas
/
Hospitales Pediátricos
/
Acetamidas
/
Antiinfecciosos
Tipo de estudio:
Observational_studies
Límite:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
Es
Revista:
Farm Hosp
Asunto de la revista:
FARMACIA
/
HOSPITAIS
Año:
2007
Tipo del documento:
Article
País de afiliación:
Argentina